Dimethyl Itaconate As A Novel Anti-Inflammatory Agent Targeting Tnf-Α-Driven Nf-Κb Activation In Epithelial Cell Models. Rev Diabet Stud 2025, 1-21. https://doi.org/10.1900/q356v768.